BofA Securities Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating

Moomoo News14:31 ET · Ratings

PepGen Stock Craters 35% on FDA Clinical Hold

Seeking AlphaDec 16 09:56 ET

Catalyst Pharmaceuticals CEO Richard J. Daly to Present at 43rd Annual J.P. Morgan Healthcare Conference

Quiver QuantitativeDec 16 08:14 ET

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Yahoo FinanceDec 3 13:27 ET

We Ran A Stock Scan For Earnings Growth And Catalyst Pharmaceuticals (NASDAQ:CPRX) Passed With Ease

Simply Wall StDec 3 07:37 ET

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500 List

Catalyst PharmaceuticalsNov 25 00:00 ET